| Issue |
Med Sci (Paris)
Volume 23, Number 3, Mars 2007
|
|
|---|---|---|
| Page(s) | 257 - 258 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2007233257 | |
| Published online | 15 March 2007 | |
La calréticuline détermine l’immunogénicité de la chimiothérapie et de la radiothérapie antitumorales
Calreticulin exposure dictates the immunogenicity of cancer cell death
Institut National de la Santé et de la Recherche Médicale, U805, Immunologie et immunothérapie des tumeurs, CIC BT507, IGR/Curie/Inserm,Faculté Paris Sud-Université Paris XI, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
Cet article ne possède pas de résumé.
© 2007 médecine/sciences - Inserm / SRMS
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
